Cliff Asness's MBX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 31,409 shares of MBX Biosciences, Inc. (MBX) worth $990,641, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Cliff Asness has maintained this position in MBX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 15,645 shares. Largest reduction occurred in Q3 2025, reducing 2,237 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's MBX Biosciences (MBX) Holding Value Over Time
Track share changes against reported price movement
Quarterly MBX Biosciences (MBX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +15,645 | Add 99.25% | 31,409 | $31.54 |
| Q3 2025 | -2,237 | Reduce 12.43% | 15,764 | $17.50 |
| Q2 2025 | +18,001 | New Buy | 18,001 | $11.41 |
Cliff Asness's MBX Biosciences Investment FAQs
Cliff Asness first purchased MBX Biosciences, Inc. (MBX) in Q2 2025, acquiring 18,001 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held MBX Biosciences, Inc. (MBX) for 3 quarters since Q2 2025.
Cliff Asness's largest addition to MBX Biosciences, Inc. (MBX) was in Q2 2025, adding 18,001 shares worth $205,392.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 31,409 shares of MBX Biosciences, Inc. (MBX), valued at approximately $990,641.
As of the Q4 2025 filing, MBX Biosciences, Inc. (MBX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in MBX Biosciences, Inc. (MBX) was 31,409 shares, as reported at the end of Q4 2025.